Jounce Therapeutics, Inc.
Anti-ICOS Antibodies for the Treatment of Cancer

Last updated:

Abstract:

Methods of treating cancer with multiple doses of anti-ICOS antibodies and multiple doses of anti-CTLA4 antibodies are provided.

Status:
Application
Type:

Utility

Filling date:

10 Mar 2020

Issue date:

5 May 2022